Evidence map›Paper›PMID 41626053›Full record

ArticleInternational journal of endocrinology2026

Effect of

Kazuya Kusama, Chisaki Fujii, Kanoko Yoshida, Mikihiro Yoshie, Yoshiyuki Adachi, Hiroaki Miyaoka, Kazuhiro Tamura

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Effect ofInternational journal of endocrinology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazuya KusamaLaboratory of Endocrine Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392, Japan, toyaku.ac.jp.ORCID https://orcid.org/0000-0002-9120-0475
Chisaki FujiiLaboratory of Endocrine Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392, Japan, toyaku.ac.jp.
Kanoko YoshidaLaboratory of Endocrine Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392, Japan, toyaku.ac.jp.ORCID https://orcid.org/0000-0001-8720-9568
Mikihiro YoshieLaboratory of Endocrine Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392, Japan, toyaku.ac.jp.ORCID https://orcid.org/0000-0001-5898-7950
Yoshiyuki AdachiLaboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392, Japan, toyaku.ac.jp.ORCID https://orcid.org/0000-0001-7164-6237
Hiroaki MiyaokaDepartment of Biomolecular Organic Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392, Japan, toyaku.ac.jp.ORCID https://orcid.org/0000-0003-2486-0403
Kazuhiro TamuraLaboratory of Endocrine Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, 192-0392, Japan, toyaku.ac.jp.ORCID https://orcid.org/0000-0003-3351-895X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing global prevalence of obesity, exacerbated by factors such as high-fat diets and reduced physical activity, poses a substantial risk for lifestyle-related diseases, particularly in postmenopausal women. Premenopausal women initially have a lower incidence of cardiovascular disease than men, but this risk increases after menopause, highlighting menopause as a critical risk factor. Our previous study showed that the extract of

Indexed as

adipose differentiationcellular senescenceCordyceps militarisovariectomy

Identifiers

PMID41626053
PMCPMC12853315

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.